This snapshot, taken on 19/01/2012, shows web content selected for preservation by The National Archives. External links, forms and search boxes may not work in archived websites.
Skip to main content
Competition Commission
Competition Commission logo
Search everything
Search reports
Search press releases
Search for inquiry

Media

News release archive

2002

2002: February


11/02
26 February 2002

INQUIRY INTO THE ACQUISITION OF McKECHNIE PAXTON HOLDINGS LIMITED BY LINPAC GROUP LIMITED

Statement of Hypothetical Remedies

The Competition Commission has sent a remedies letter, on a purely hypothetical basis, to the Linpac Group Limited (Linpac), as part of its inquiry into the acquisition by Linpac of McKechnie Paxton Holdings Limited (Paxton).

This statement summarises the points on which views are being sought. In particular, comments are invited on the likely effectiveness, costs and practicability of the remedies that have been set out. It should be clearly understood that the basis on which the points listed below are being raised is entirely hypothetical. It does not imply that the Commission has reached any conclusion on whether the acquisition is likely to be against the public interest. It is being published now to give interested parties as much time as possible to comment on the possible remedies that the Commission may consider, consistent with maintaining the schedule for the inquiry.

The Commission invites views on a number of hypothetical remedies:

  • a complete divestment of one or more of Linpac’s UK subsidiaries operating in the markets for returnable transit packaging (RTP), or a partial divestment of factories or operations relating to specific products or services where adverse effects may be identified;
  • a divestment, by Linpac, of vertically integrated logistics businesses using RTP, and an undertaking, not to recreate any;
  • an undertaking to make transparent to customers that Paxton is now part of the Linpac group, and no longer a competitor;
  • an undertaking that Linpac would not seek to enforce intellectual property rights for various RTP products either, at all or for a limited period of time only; and would make information on design and manufacture freely available to competitors;
  • undertakings relating to Linpac’s UK subsidiaries about the prices of RTP and other plastic-based, transit packaging items. These could take a number of forms, could be imposed for varying periods of time, and could be adjusted for changes in raw material costs. Measures might include:
    • undertakings, on the part of the UK subsidiaries, relating to the level of prices charged to customers, or to the mechanisms by which they are set; and/or
    • an undertaking that the UK subsidiaries would publish their prices and/or notify all their customers of them.

Other remedies, which would go along with those listed above, include:

    • an undertaking to inform all customers of undertakings given;
    • an undertaking to seek prior clearance from the OFT for further acquisitions in any of the markets affected by the current acquisition;
    • an undertaking to assist the OFT in monitoring compliance with behavioural undertakings, including the provision of pricing data.

Responses

Comments are invited on the hypothetical remedies described in this statement. It would be helpful if responses could be sent to the Reference Secretary, Peter Radley, at the Competition Commission, New Court, 48 Carey Street, London, WC2A 2JT (telephone 020 7271 0394, fax 020 7271 0203, e-mail linpac@competition-commission.gsi.gov.uk) by Monday, 11 March.

Notes to editors

1. The reference was made by the Secretary of State for Trade and Industry, under section 64(8) of the Fair Trading Act 1973, on 4 January 2002 (see DTI press release P/2002/003).

  1. No conclusion will be reached about whether any matters operate or may be expected to operate against the public interest until the Competition Commission submits its report to the Secretary of State on 10 April 2002.
  2. The Statement of Issues were set out in Competition Commission News Release 08/02, dated 12 February 2002.
  3. This inquiry is being undertaken by a group of five Commission members and is led by Denise Kingsmill, one of the Commission’s two deputy chairmen. The other members are Christopher Clarke, a former director of HSBC Investment Banking, Dame Helena Shovelton, the Chief Executive of the British Lung Foundation, Professor Catherine Waddams, Director of the Centre for Competition and Regulation at the University of East Anglia and Martyn Webster, former Group Managing Director of Southern Water plc.
  4. Further information can be obtained from the Commission’s website at www.competition-commission.org.uk/inquiries/ref.htm
  5. Enquiries should be directed to: Francis Royle, Press Officer (020 7271 0242).